FXH Among Health Care ETFs
End-of-day Nov 20, 2026 · 31 Health care ETFs by 3Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.2% | −6.7% | −5.6% | −4.2% | +13.8% | +16.3% | +38.6% | +8.7% | +128.4% | +563.7% |
| Peer average | −1.3% | −6.4% | −4.5% | −5.9% | +13.4% | +17.5% | +58.2% | +19.5% | +146.1% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$27 of every $1,000 in FXH is Zimmer
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | ZBHZimmer Biomet | Healthcare | 2.72% | $272.08 | 301K | $30.5M |
| 2 | CNCCentene | Healthcare | 2.51% | $251.45 | 430K | $28.2M |
| 3 | MEDPMedpace | Healthcare | 2.42% | $241.93 | 43K | $27.1M |
| 4 | CIThe Cigna Group | Healthcare | 2.39% | $239.25 | 98K | $26.8M |
| 5 | UHSUniversal Health Services, () | Healthcare | 2.39% | $239.17 | 153K | $26.8M |
| 6 | GEHCGE HealthCare Technologies | Healthcare | 2.39% | $238.71 | 327K | $26.8M |
| 7 | REGNRegeneron Pharmaceuticals | Healthcare | 2.32% | $232.03 | 28K | $26.0M |
| 8 | SOLVSolventum | Healthcare | 2.32% | $231.84 | 303K | $26.0M |
| 9 | LLYEli Lilly and Company | Healthcare | 2.23% | $222.52 | 18K | $25.0M |
| 10 | DXCMDexCom | Healthcare | 2.21% | $221.35 | 310K | $24.8M |
| 11 | ZTSZoetis | Healthcare | 2.20% | $220.46 | 306K | $24.7M |
| 12 | GMEDGlobus Medical, () | Healthcare | 2.18% | $218.15 | 357K | $24.5M |
| 13 | EXELExelixis | Healthcare | 2.15% | $214.76 | 366K | $24.1M |
| 14 | MDTMedtronic | Healthcare | 2.13% | $212.80 | 237K | $23.9M |
| 15 | COOThe Cooper Companies | Healthcare | 2.03% | $203.36 | 378K | $22.8M |
of the $108B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | ZBH | Zimmer Biomet | 2.72% |
| 2 | CNC | Centene | 2.51% |
| 3 | MEDP | Medpace | 2.42% |
| 4 | CI | The Cigna Group | 2.39% |
| 5 | UHS | Universal Health Services, () | 2.39% |
| 6 | GEHC | GE HealthCare Technologies | 2.39% |
| 7 | REGN | Regeneron Pharmaceuticals | 2.32% |
| 8 | SOLV | Solventum | 2.32% |
| 9 | LLY | Eli Lilly and Company | 2.23% |
| 10 | DXCM | DexCom | 2.21% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 24, 2026 | Sep 30, 2026 | $0.29 |
| Jun 25, 2026 | Jun 30, 2026 | $0.12 |
| Mar 26, 2026 | Mar 31, 2026 | $0.19 |
| Dec 12, 2025 | Dec 31, 2025 | $0.14 |
| Sep 25, 2025 | Sep 30, 2025 | $0.58 |
| Jun 26, 2025 | Jun 30, 2025 | $0.0616 |
| Mar 27, 2025 | Mar 31, 2025 | $0.0669 |
| Dec 13, 2024 | Dec 31, 2024 | $0.0899 |
| Sep 26, 2024 | Sep 30, 2024 | $0.13 |
| Jun 27, 2024 | Jun 28, 2024 | $0.11 |
| Mar 21, 2024 | Mar 28, 2024 | $0.11 |
| Dec 22, 2023 | Dec 29, 2023 | $0.13 |